370 related articles for article (PubMed ID: 22275851)
1. NMDA receptors and fear extinction: implications for cognitive behavioral therapy.
Davis M
Dialogues Clin Neurosci; 2011; 13(4):463-74. PubMed ID: 22275851
[TBL] [Abstract][Full Text] [Related]
2. Reconsolidation and extinction of conditioned fear: inhibition and potentiation.
Lee JL; Milton AL; Everitt BJ
J Neurosci; 2006 Sep; 26(39):10051-6. PubMed ID: 17005868
[TBL] [Abstract][Full Text] [Related]
3. Effects of D-cycloserine on extinction: translation from preclinical to clinical work.
Davis M; Ressler K; Rothbaum BO; Richardson R
Biol Psychiatry; 2006 Aug; 60(4):369-75. PubMed ID: 16919524
[TBL] [Abstract][Full Text] [Related]
4. D-cycloserine facilitates extinction the first time but not the second time: an examination of the role of NMDA across the course of repeated extinction sessions.
Langton JM; Richardson R
Neuropsychopharmacology; 2008 Dec; 33(13):3096-102. PubMed ID: 18354389
[TBL] [Abstract][Full Text] [Related]
5. d-Cycloserine facilitates fear extinction in adolescent rats and differentially affects medial and lateral prefrontal cortex activation.
Baker KD; McNally GP; Richardson R
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():262-269. PubMed ID: 29928912
[TBL] [Abstract][Full Text] [Related]
6. Astrocytic NMDA Receptors in the Basolateral Amygdala Contribute to Facilitation of Fear Extinction.
Shelkar GP; Liu J; Dravid SM
Int J Neuropsychopharmacol; 2021 Nov; 24(11):907-919. PubMed ID: 34363482
[TBL] [Abstract][Full Text] [Related]
7. A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy.
Norberg MM; Krystal JH; Tolin DF
Biol Psychiatry; 2008 Jun; 63(12):1118-26. PubMed ID: 18313643
[TBL] [Abstract][Full Text] [Related]
8. Neurobiology of anxiety disorders and implications for treatment.
Garakani A; Mathew SJ; Charney DS
Mt Sinai J Med; 2006 Nov; 73(7):941-9. PubMed ID: 17195879
[TBL] [Abstract][Full Text] [Related]
9. Combining D-cycloserine with appetitive extinction learning modulates amygdala activity during recall.
Ebrahimi C; Koch SP; Friedel E; Crespo I; Fydrich T; Ströhle A; Heinz A; Schlagenhauf F
Neurobiol Learn Mem; 2017 Jul; 142(Pt B):209-217. PubMed ID: 28512009
[TBL] [Abstract][Full Text] [Related]
10. Augmenting extinction learning with D-cycloserine reduces return of fear: a randomized, placebo-controlled fMRI study.
Ebrahimi C; Gechter J; Lueken U; Schlagenhauf F; Wittchen HU; Hamm AO; Ströhle A
Neuropsychopharmacology; 2020 Feb; 45(3):499-506. PubMed ID: 31634897
[TBL] [Abstract][Full Text] [Related]
11. Opposing effects of D-cycloserine on fear despite a common extinction duration: interactions between brain regions and behavior.
Bolkan SS; Lattal KM
Neurobiol Learn Mem; 2014 Sep; 113():25-34. PubMed ID: 24374132
[TBL] [Abstract][Full Text] [Related]
12. Role of NMDA receptors and MAP kinase in the amygdala in extinction of fear: clinical implications for exposure therapy.
Davis M
Eur J Neurosci; 2002 Aug; 16(3):395-8. PubMed ID: 12193180
[TBL] [Abstract][Full Text] [Related]
13. Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats.
Walker DL; Ressler KJ; Lu KT; Davis M
J Neurosci; 2002 Mar; 22(6):2343-51. PubMed ID: 11896173
[TBL] [Abstract][Full Text] [Related]
14. The effects of midazolam and D-cycloserine on the release of glutamate and GABA in the basolateral amygdala of low and high anxiety rats during extinction trial of a conditioned fear test.
Lehner M; Wisłowska-Stanek A; Taracha E; Maciejak P; Szyndler J; Skórzewska A; Turzyńska D; Sobolewska A; Hamed A; Bidziński A; Płaźnik A
Neurobiol Learn Mem; 2010 Nov; 94(4):468-80. PubMed ID: 20807585
[TBL] [Abstract][Full Text] [Related]
15. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear.
Ressler KJ; Rothbaum BO; Tannenbaum L; Anderson P; Graap K; Zimand E; Hodges L; Davis M
Arch Gen Psychiatry; 2004 Nov; 61(11):1136-44. PubMed ID: 15520361
[TBL] [Abstract][Full Text] [Related]
16. Targeting the NMDA receptor for fear-related disorders.
Amaral OB; Roesler R
Recent Pat CNS Drug Discov; 2008 Nov; 3(3):166-78. PubMed ID: 18991806
[TBL] [Abstract][Full Text] [Related]
17. Administration of riluzole to the basolateral amygdala facilitates fear extinction in rats.
Sugiyama A; Yamada M; Saitoh A; Oka JI; Yamada M
Behav Brain Res; 2018 Jan; 336():8-14. PubMed ID: 28843863
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of GluN2C/D NMDA receptor subtypes in the amygdala facilitates the retention of fear and extinction learning in mice.
Ogden KK; Khatri A; Traynelis SF; Heldt SA
Neuropsychopharmacology; 2014 Feb; 39(3):625-37. PubMed ID: 24008353
[TBL] [Abstract][Full Text] [Related]
19. Amygdaloid zif268 participated in the D-cycloserine facilitation effect on the extinction of conditioned fear.
Wu IT; Tang TH; Ko MC; Chiu CY; Lu KT
Psychopharmacology (Berl); 2015 Oct; 232(20):3809-19. PubMed ID: 26282370
[TBL] [Abstract][Full Text] [Related]
20. Role of the amygdala in fear extinction measured with potentiated startle.
Davis M; Walker DL; Myers KM
Ann N Y Acad Sci; 2003 Apr; 985():218-32. PubMed ID: 12724161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
